{"transactions":[{"id":1567662,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92868,"kind":"person","name":"Schroeder Blake","position":1,"cik":"0001708685","reported_name":"Schroeder Blake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Note","published_at":"2024-03-19T19:37:27.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":35000,"value":1225000000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting Person acquired a convertible note, face value $35,000.  The note is convertible into shares of the Issuer's common stock at a price of $0.01 per share."}],"balance_after":4500000,"derivative":{"exercise_price":0.01,"exercise_date":"2024-03-15","expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":3500000},"source":{"system":"sec-edgar","filing":"0001096906-24-000522","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690624000522/form4.xml","form_type":"4"}},{"id":2151783,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92868,"kind":"person","name":"Schroeder Blake","position":1,"cik":"0001708685","reported_name":"Schroeder Blake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2022-09-23T18:06:08.000Z","date":"2022-09-23","kind":"grant","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting Person acquired an option to purchase up to 1,000,000 shares of common stock. 50% of the shares may be purchased immediately and the remaining 50% of the shares may purchased at the date which is six (6) months following the grant date."}],"balance_after":1000000,"derivative":{"exercise_price":0.052,"expiration_date":"2032-08-22","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001096906-22-002340","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002340/form4.xml","form_type":"4"}},{"id":2172665,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92868,"kind":"person","name":"Schroeder Blake","position":1,"cik":"0001708685","reported_name":"Schroeder Blake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-26T17:05:16.000Z","date":"2022-08-22","kind":"exercise","acquired":true,"shares":854012,"price":0.029,"value":24766.348,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Conversion of Note"}],"balance_after":854012,"source":{"system":"sec-edgar","filing":"0001096906-22-002027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002027/form4.xml","form_type":"4"}},{"id":2394041,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92868,"kind":"person","name":"Schroeder Blake","position":1,"cik":"0001708685","reported_name":"Schroeder Blake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Note (Convertible into Common Stock)","published_at":"2022-02-15T18:04:17.000Z","date":"2022-02-10","kind":"other","acquired":true,"shares":25000,"price":25000,"value":625000000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Note bears interest at a rate of 3% per annum.  At the election of the Reporting Person, all principal and accrued interest under the  Note may be converted into the Issuer's common stock at a converstion price equal to the lesser of $0.08125 or 70% of the average of the two lowest closing prices of the Issuer's common stock in the ten (10) days prior to the date of conversion."}],"balance_after":307692,"derivative":{"exercise_price":0.0812,"exercise_date":"2022-02-10","expiration_date":"2032-02-10","underlying":"Common Stock","underlying_shares":307692},"source":{"system":"sec-edgar","filing":"0001096906-22-000339","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000339/form4.xml","form_type":"4"}},{"id":2785427,"issuer":{"id":126275,"kind":"organization","name":"NEUROPATHIX, INC.","symbol":"NPTX"},"owners":[{"id":92868,"kind":"person","name":"Schroeder Blake","position":1,"cik":"0001708685","reported_name":"Schroeder Blake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-03-16T16:56:37.000Z","date":"2021-03-12","kind":"grant","acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the option shares vest on the date of grant and the remaining option shares vest in equal monthly installments over 36 months thereafter."}],"balance_after":600000,"derivative":{"exercise_price":0.13,"expiration_date":"2031-03-11","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001607062-21-000052","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615999/000160706221000052/primary_doc.xml","form_type":"4"}},{"id":3159120,"issuer":{"id":126275,"kind":"organization","name":"NEUROPATHIX, INC.","symbol":"NPTX"},"owners":[{"id":92868,"kind":"person","name":"Schroeder Blake","position":1,"cik":"0001708685","reported_name":"Schroeder Blake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-06T21:47:16.000Z","date":"2020-05-04","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the option shares vest on the date of grant and the remaining option shares vest in equal monthly installments over 36 months commencing with the\nvesting commencement date of January 1, 2020."}],"balance_after":300000,"derivative":{"exercise_price":0.57,"expiration_date":"2030-05-03","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001683168-20-001432","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615999/000168316820001432/ownership.xml","form_type":"4"}},{"id":3159118,"issuer":{"id":126275,"kind":"organization","name":"NEUROPATHIX, INC.","symbol":"NPTX"},"owners":[{"id":92868,"kind":"person","name":"Schroeder Blake","position":1,"cik":"0001708685","reported_name":"Schroeder Blake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-06T21:39:55.000Z","date":"2019-08-14","kind":"grant","acquired":true,"shares":250000,"price":0.1,"value":25000.0,"ownership":{"direct":true},"balance_after":250000,"source":{"system":"sec-edgar","filing":"0001683168-20-001425","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615999/000168316820001425/ownership.xml","form_type":"4"}}]}